Monday, May 18, 2015

FDA Warns of Ketoacidosis Risk with Newer Diabetes Drugs

Typically used in Type 2 Diabetes they decrease glucose absorption and increase urinary glucose excretion.


FDA Warns of Ketoacidosis Risk with Newer Diabetes Drugs
Posted by at
Labels: ,
Location: College Point, NY 11356, USA

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)